SEC Form 4 · accession 0001209191-17-007894
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ravi S. Chari
Officer — SVP-Clinical Excellence
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 7:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2017 | S | 15,901 | $82.00 | D | 10,247 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $81.96 | Feb 1, 2017 | A | 14,680 | A | Feb 1, 2018 | Feb 1, 2027 | Common Stock | 14,680 | 14,680 | D |
Explanation of responses
- F1The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018.